{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:59:17Z","timestamp":1791403157197,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["114027006"],"award-info":[{"award-number":["114027006"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tox.2025.154267","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T15:00:34Z","timestamp":1755961234000},"page":"154267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["FOXO3 mediated gene expression modulates doxorubicin sensitivity in human cardiomyocytes"],"prefix":"10.1016","volume":"518","author":[{"given":"J.G.","family":"Faber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van Herwijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Daemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Caiment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"van den Beucken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.tox.2025.154267_bib1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/02841860601156165","article-title":"Anthracycline-induced chronic cardiotoxicity and heart failure","volume":"46","author":"Appel","year":"2007","journal-title":"Acta Oncol."},{"issue":"2","key":"10.1016\/j.tox.2025.154267_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIRCRESAHA.117.312395","article-title":"Anthracycline cardiotoxicity: worrisome enough to have you quaking?","volume":"122","author":"Bernstein","year":"2018","journal-title":"Circ. Res"},{"issue":"22","key":"10.1016\/j.tox.2025.154267_bib3","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.tox.2025.154267_bib4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med"},{"key":"10.1016\/j.tox.2025.154267_bib5","first-page":"1","article-title":"Molecular mechanisms of anthracycline activity","volume":"283","author":"Beretta","year":"2008","journal-title":"Top. Curr. Chem."},{"issue":"4","key":"10.1016\/j.tox.2025.154267_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7150\/ijbs.6058","article-title":"Genomic profiling reveals the potential role of TCL1A and MDR1 deficiency in chemotherapy-induced cardiotoxicity","volume":"9","author":"McCaffrey","year":"2013","journal-title":"Int J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2025.154267_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"Sim\u016fnek","year":"2009","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.tox.2025.154267_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/795602","article-title":"Chemotherapy-Induced cardiotoxicity: overview of the roles of oxidative stress","volume":"2015","author":"Angsutararux","year":"2015","journal-title":"Oxid. Med Cell Longev."},{"issue":"9","key":"10.1016\/j.tox.2025.154267_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091110","article-title":"FOXO3a from the nucleus to the mitochondria: a round trip in cellular stress response","volume":"8","author":"Fasano","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.tox.2025.154267_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101621","article-title":"Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity","volume":"78","author":"McIntyre","year":"2022","journal-title":"Ageing Res Rev."},{"issue":"10","key":"10.1016\/j.tox.2025.154267_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41419-023-06177-1","article-title":"FOXO family isoforms","volume":"14","author":"Santos","year":"2023","journal-title":"Cell Death Dis."},{"issue":"16","key":"10.1016\/j.tox.2025.154267_bib12","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/onc.2008.21","article-title":"The FoxO code","volume":"27","author":"Calnan","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2025.154267_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fphar.2020.00625","article-title":"Small molecule inhibitors of CRM1","volume":"11","author":"Ferreira","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.tox.2025.154267_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.ctdb.2017.10.006","article-title":"Regulation of FOXO factors in mammalian cells","volume":"127","author":"Brown","year":"2018","journal-title":"Curr. Top. Dev. Biol."},{"issue":"12","key":"10.1016\/j.tox.2025.154267_bib15","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","article-title":"FOXO transcription factors as therapeutic targets in human diseases","volume":"43","author":"Orea-Soufi","year":"2022","journal-title":"Trends Pharm. Sci."},{"issue":"37","key":"10.1016\/j.tox.2025.154267_bib16","doi-asserted-by":"crossref","first-page":"13987","DOI":"10.1073\/pnas.0801030105","article-title":"FOXO3A genotype is strongly associated with human longevity","volume":"105","author":"Willcox","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.tox.2025.154267_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/acel.12452","article-title":"The FoxO3 gene and cause-specific mortality","volume":"15","author":"Willcox","year":"2016","journal-title":"Aging Cell"},{"issue":"7","key":"10.1016\/j.tox.2025.154267_bib18","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.ajpath.2018.04.007","article-title":"Increasing cardiomyocyte Atrogin-1 reduces Aging-Associated fibrosis and regulates remodeling in vivo","volume":"188","author":"Mota","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.tox.2025.154267_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-020-0088-2","article-title":"Therapeutic strategies targeting FOXO transcription factors","volume":"20","author":"Calissi","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tox.2025.154267_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153977","article-title":"Knock-down of FOXO3, GATA2, NFE2L2 and AHR promotes doxorubicin-induced cardiotoxicity in human cardiomyocytes","volume":"509","author":"Faber","year":"2024","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.tox.2025.154267_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.tox.2025.154267_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-7-3","article-title":"The RIN: an RNA integrity number for assigning integrity values to RNA measurements","volume":"7","author":"Schroeder","year":"2006","journal-title":"BMC Mol. Biol."},{"issue":"1","key":"10.1016\/j.tox.2025.154267_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac582","article-title":"CODA: a combo-Seq data analysis workflow","volume":"24","author":"Nazzari","year":"2023","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.tox.2025.154267_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105143","article-title":"R-ODAF: omics data analysis framework for regulatory application","volume":"131","author":"Verheijen","year":"2022","journal-title":"Regul. Toxicol. Pharm."},{"issue":"1","key":"10.1016\/j.tox.2025.154267_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tox.2025.154267_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinforma."},{"issue":"12","key":"10.1016\/j.tox.2025.154267_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.tox.2025.154267_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"Imeta"},{"issue":"1","key":"10.1016\/j.tox.2025.154267_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1467-985X.2010.00676_9.x","article-title":"ggplot2: elegant graphics for data analysis","volume":"174","author":"Ginestet","year":"2011","journal-title":"J. R. Stat. Soc. Ser. A Stat. Soc."},{"issue":"5","key":"10.1016\/j.tox.2025.154267_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: an r package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"issue":"11","key":"10.1016\/j.tox.2025.154267_bib31","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"11","key":"10.1016\/j.tox.2025.154267_bib32","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00204-015-1623-5","article-title":"Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment","volume":"90","author":"Chaudhari","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2025.154267_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.taap.2018.07.020","article-title":"RNA sequence analysis of inducible pluripotent stem cell-derived cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin","volume":"356","author":"Reyes","year":"2018","journal-title":"Toxicol. Appl. Pharm."},{"issue":"6","key":"10.1016\/j.tox.2025.154267_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/cdd.2011.179","article-title":"FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression","volume":"19","author":"Ferber","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tox.2025.154267_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinforma."},{"issue":"6","key":"10.1016\/j.tox.2025.154267_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000375235","article-title":"FOXO3: a major gene for human Longevity--A Mini-Review","volume":"61","author":"Morris","year":"2015","journal-title":"Gerontology"},{"key":"10.1016\/j.tox.2025.154267_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.freeradbiomed.2017.01.037","article-title":"Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2","volume":"104","author":"Zhou","year":"2017","journal-title":"Free Radic. Biol. Med"},{"issue":"44","key":"10.1016\/j.tox.2025.154267_bib38","doi-asserted-by":"crossref","first-page":"29730","DOI":"10.1074\/jbc.M805514200","article-title":"Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase","volume":"283","author":"Tan","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.tox.2025.154267_bib39","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.celrep.2013.11.031","article-title":"FOXO3 selectively amplifies enhancer activity to establish target gene regulation","volume":"5","author":"Eijkelenboom","year":"2013","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.tox.2025.154267_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2020.05.040","article-title":"A genetic map of the response to DNA damage in human cells","volume":"182","author":"Olivieri","year":"2020","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.tox.2025.154267_bib41","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bbamcr.2011.05.001","article-title":"Bimodal regulation of FoxO3 by AKT and 14-3-3","volume":"1813","author":"Dobson","year":"2011","journal-title":"Biochim Biophys. Acta"},{"issue":"6","key":"10.1016\/j.tox.2025.154267_bib42","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3892\/ijmm.2016.2563","article-title":"Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K\/Akt\/FoxO3a pathway","volume":"37","author":"Liu","year":"2016","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.tox.2025.154267_bib43","doi-asserted-by":"crossref","first-page":"7420196","DOI":"10.1155\/2019\/7420196","article-title":"Thyroxine alleviates energy failure, prevents myocardial cell apoptosis, and protects against Doxorubicin-Induced cardiac injury and cardiac dysfunction via the LKB1\/AMPK\/mTOR axis in mice","volume":"2019","author":"Wang","year":"2019","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.tox.2025.154267_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5603\/CJ.a2017.0018","article-title":"Sevoflurane ameliorates doxorubicin-induced myocardial injury by affecting the phosphorylation states of proteins in PI3K\/Akt\/mTOR signaling pathway","volume":"24","author":"Wu","year":"2017","journal-title":"Cardiol. J."},{"issue":"4","key":"10.1016\/j.tox.2025.154267_bib45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.21037\/cdt-19-707","article-title":"Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K\/Akt\/mTOR-dependent manner","volume":"10","author":"Yu","year":"2020","journal-title":"Cardiovasc Diagn. Ther."},{"issue":"1","key":"10.1016\/j.tox.2025.154267_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/bab.2648","article-title":"The interplay between doxorubicin chemotherapy, antioxidant system, and cardiotoxicity: unrevealing of the protective potential of tannic acid","volume":"72","author":"Kansu","year":"2025","journal-title":"Biotechnol. Appl. Biochem"},{"key":"10.1016\/j.tox.2025.154267_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153597","article-title":"Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms","volume":"494","author":"Zhuo","year":"2023","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.tox.2025.154267_bib48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s10753-023-01908-0","article-title":"The role of Nrf2 and inflammation on the dissimilar cardiotoxicity of doxorubicin in Two-Time points: a Cardio-Oncology in vivo study through time","volume":"47","author":"Reis-Mendes","year":"2024","journal-title":"Inflammation"},{"issue":"23","key":"10.1016\/j.tox.2025.154267_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238623","article-title":"FOXO3a mediates homologous recombination repair (HRR) via transcriptional activation of MRE11, BRCA1, BRIP1, and RAD50","volume":"27","author":"Inci","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.tox.2025.154267_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13184","article-title":"FOXO3a acts to suppress DNA double-strand break-induced mutations","volume":"19","author":"White","year":"2020","journal-title":"Aging Cell"},{"issue":"29","key":"10.1016\/j.tox.2025.154267_bib51","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1038\/onc.2011.35","article-title":"The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor","volume":"30","author":"Renault","year":"2011","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.tox.2025.154267_bib52","doi-asserted-by":"crossref","first-page":"9051","DOI":"10.1073\/pnas.0600889103","article-title":"Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a","volume":"103","author":"You","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1-2","key":"10.1016\/j.tox.2025.154267_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00109-022-02281-5","article-title":"FoxO3 and oxidative stress: a multifaceted role in cellular adaptation","volume":"101","author":"Bernardo","year":"2023","journal-title":"J. Mol. Med (Berl. )"},{"issue":"2","key":"10.1016\/j.tox.2025.154267_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm3507","article-title":"FOXOs: signalling integrators for homeostasis maintenance","volume":"14","author":"Eijkelenboom","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.tox.2025.154267_bib55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","article-title":"p53: 800 million years of evolution and 40 years of discovery","volume":"20","author":"Levine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.tox.2025.154267_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tibs.2014.02.003","article-title":"FOXO transcription factors: key regulators of cellular quality control","volume":"39","author":"Webb","year":"2014","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.tox.2025.154267_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121877","article-title":"The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts","volume":"328","author":"Cao","year":"2023","journal-title":"Life Sci."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X25002264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X25002264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:27:05Z","timestamp":1778682425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X25002264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S0300483X25002264"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2025.154267","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXO3 mediated gene expression modulates doxorubicin sensitivity in human cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2025.154267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"154267"}}